TY - JOUR
T1 - Reduced exercise capacity and clinical outcomes following acute myocardial infarction
AU - Tashiro, Hiroshi
AU - Tanaka, Akihito
AU - Ishii, Hideki
AU - Motomura, Nariko
AU - Arai, Kenji
AU - Adachi, Takeshi
AU - Okajima, Takashi
AU - Iwakawa, Naoki
AU - Kojima, Hiroki
AU - Mitsuda, Takayuki
AU - Hirayama, Kenshi
AU - Hitora, Yusuke
AU - Hayashi, Motoharu
AU - Furusawa, Kenji
AU - Yoshida, Ruka
AU - Imai, Hajime
AU - Ogawa, Yasuhiro
AU - Kawaguchi, Katsuhiro
AU - Murohara, Toyoaki
N1 - Publisher Copyright:
© 2020, Springer Japan KK, part of Springer Nature.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Reduced exercise capacity is known to be an important predictor of poor prognosis and disability in patients with cardiovascular diseases and chronic heart failure, and even members of the general population. However, data about exercise capacity assessed by cardiopulmonary exercise testing (CPX) in acute myocardial infarction (AMI) patients who underwent primary percutaneous coronary intervention (PCI) is scarce. Among 594 consecutive AMI patients who underwent primary PCI, we examined 136 patients (85.3% men, 64.9 ± 11.9 years) who underwent CPX during hospitalization for AMI. CPX was usually performed 5 days after the onset of AMI. Reduced exercise capacity was defined as peak VO2 ≤ 12. Clinical outcomes including all-cause death, myocardial infarction, and hospitalization due to heart failure were followed. Among 136 patients, reduced exercise capacity (peak VO2 ≤ 12) was seen in 38 patients (28%). Patients with reduced exercise capacity were older, more likely to have hypertension, and had lower renal function. In echocardiography, patients with reduced exercise capacity had higher E/e’ and larger left atrial dimension. Multivariate logistic analysis showed that E/e’ (OR 1.19, 95% CI 1.09–1.31, p < 0.001) was an independent predictor of reduced exercise capacity (peak VO2 ≤ 12). Median follow-up term was 12 months (IQR 9–22). The occurrence of composite endpoints of all-cause death, myocardial infarction, and hospitalization due to heart failure was significantly higher in patients with peak VO2 ≤ 12 than those with peak VO2 > 12 (p < 0.001). Reduced exercise capacity following primary PCI in AMI patients is associated with diastolic dysfunction and may lead to poorer clinical outcomes.
AB - Reduced exercise capacity is known to be an important predictor of poor prognosis and disability in patients with cardiovascular diseases and chronic heart failure, and even members of the general population. However, data about exercise capacity assessed by cardiopulmonary exercise testing (CPX) in acute myocardial infarction (AMI) patients who underwent primary percutaneous coronary intervention (PCI) is scarce. Among 594 consecutive AMI patients who underwent primary PCI, we examined 136 patients (85.3% men, 64.9 ± 11.9 years) who underwent CPX during hospitalization for AMI. CPX was usually performed 5 days after the onset of AMI. Reduced exercise capacity was defined as peak VO2 ≤ 12. Clinical outcomes including all-cause death, myocardial infarction, and hospitalization due to heart failure were followed. Among 136 patients, reduced exercise capacity (peak VO2 ≤ 12) was seen in 38 patients (28%). Patients with reduced exercise capacity were older, more likely to have hypertension, and had lower renal function. In echocardiography, patients with reduced exercise capacity had higher E/e’ and larger left atrial dimension. Multivariate logistic analysis showed that E/e’ (OR 1.19, 95% CI 1.09–1.31, p < 0.001) was an independent predictor of reduced exercise capacity (peak VO2 ≤ 12). Median follow-up term was 12 months (IQR 9–22). The occurrence of composite endpoints of all-cause death, myocardial infarction, and hospitalization due to heart failure was significantly higher in patients with peak VO2 ≤ 12 than those with peak VO2 > 12 (p < 0.001). Reduced exercise capacity following primary PCI in AMI patients is associated with diastolic dysfunction and may lead to poorer clinical outcomes.
KW - Acute myocardial infarction
KW - CPX
KW - Exercise capacity
UR - http://www.scopus.com/inward/record.url?scp=85081241473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081241473&partnerID=8YFLogxK
U2 - 10.1007/s00380-020-01576-2
DO - 10.1007/s00380-020-01576-2
M3 - Article
C2 - 32152731
AN - SCOPUS:85081241473
SN - 0910-8327
VL - 35
SP - 1044
EP - 1050
JO - Heart and Vessels
JF - Heart and Vessels
IS - 8
ER -